SWKHL
SWK Holdings Corp
0.00 (0.00%)25.09USD714成交股數303M市值–本益比(近四季)141.0股價營收比-100.0%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 0-100% | 0-100% | 1.2M+327% | 963K-105% | 628K+99% | 804K-92% | 279K-97% | −18.0M-232% | 315K | 9.5M | 9.4M | 13.6M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1K | 147K | 645K | 758K | 585K | 520K | 530K | 602K | 606K | 1.5M | 719K | 1.8M |
| 銷售管理費用 | 5.4M | 3.3M | 2.8M | 3.3M | 3.0M | 2.9M | 2.7M | 2.7M | 3.0M | 3.0M | 2.5M | 4.3M |
| 營業利益 | 857K-79% | 6.7M+641% | 4.6M+329% | 8.1M | 4.1M-6% | 901K | 1.1M | – | 4.3M | – | – | 6.8M |
| 營業利益率 | – | – | 389.0% | 842.5% | 650.0% | 112.1% | 386.7% | – | 1,373.3% | – | – | 49.6% |
| 稅後淨利 | −19.4M-659% | 8.8M+139% | 3.5M+656% | 4.5M+60% | 3.5M-22% | 3.7M-6% | 468K-90% | 2.8M-57% | 4.5M | 3.9M | 4.6M | 6.6M |
| 淨利率 | – | – | 297.1% | 471.3% | 552.2% | 457.7% | 167.7% | -15.8% | 1,420.3% | 41.4% | 49.3% | 48.6% |
| 稀釋 EPS | -1.59-668% | 0.72+140% | 0.29+625% | 0.37+68% | 0.28-22% | 0.30-3% | 0.04-89% | 0.22-57% | 0.36 | 0.31 | 0.36 | 0.51 |
| 稀釋股數 | 12.2M | 12.1M | 12.2M | 12.2M | 12.4M | 12.5M | 12.5M | 12.7M | 12.6M | 12.8M | 12.9M | 12.9M |
資產負債表 期末餘額
| 科目 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 42.8M | 10.2M | 8.0M | 29.8M | 17.2M | 5.5M | 5.5M | 4.5M | 31.0M | 6.8M | 3.2M | 19.4M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 272M | 289M | 286M | 331M | 321M | 321M | 322M | 334M | 316M | 290M | 301M | 292M |
| 有息負債 | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M | 33.0M | – | – | – | – |
| 總負債 | 37.3M | 35.2M | 39.2M | 38.6M | 37.8M | 38.2M | 42.1M | 53.9M | 38.3M | 16.6M | 26.4M | 14.8M |
| 股東權益 | 235M | 254M | 246M | 293M | 283M | 283M | 280M | 280M | 278M | 274M | 274M | 277M |
| 負債比 | 13.7% | 12.1% | 13.7% | 11.7% | 11.8% | 11.9% | 13.1% | 16.1% | 12.1% | 5.7% | 8.8% | 5.1% |
| 淨現金(現金 − 有息負債) | 9.8M | −22.8M | −25.0M | −3.2M | −15.8M | −27.4M | −27.5M | −28.5M | – | – | – | – |
現金流量表 單季
| 科目 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 | 23Q1 | 22Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | – | 8.3M | – | – | 4.4M+567% | – | – | – | 664K | – |
| 資本支出 | – | – | – | 100K | – | – | 0 | – | – | – | 8K | – |
| 自由現金流 | – | – | – | 8.2M | – | – | 4.4M+575% | – | – | – | 656K | – |
| 折舊攤銷 | 0 | 2K | 19K | 19K | 234K | 421K | 514K | 640K | 652K | 637K | 648K | 634K |
| 買回庫藏股 | – | – | – | 867K | – | – | 999K | – | – | – | 531K | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | 849.4% | – | – | 1,587.8% | – | – | – | 7.0% | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.2M
| Pharmaceutical Development | 2.2M | 100.0% | -40.5% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.2M | -40.5% | −2.5M | -117.6% | -0.21 | 26.8M |
| FY2024 | 3.6M | +200.8% | 13.5M | 373.0% | 1.09 | 22.9M |
| FY2023 | 1.2M | -97.1% | 15.9M | 1,321.7% | 1.25 | 14.4M |
| FY2022 | 41.5M | -26.1% | 13.5M | 32.5% | 1.05 | 7.9M |
| FY2021 | 56.2M | +53.0% | 25.9M | 46.2% | 2.02 | 33.2M |
| FY2020 | 36.7M | +19.4% | 5.2M | 14.2% | 0.40 | 15.3M |
| FY2019 | 30.7M | +18.3% | 23.8M | 77.5% | 1.85 | 18.5M |
| FY2018 | 26.0M | – | 6.2M | 23.8% | 0.47 | – |